Skip to main content

All Medical Tests

Browse our complete catalog of diagnostic tests.

Achondroplasia (FGFR3 Full Gene Sequence Analysis) Test

Achondroplasia (FGFR3 Full Gene Sequence Analysis) Test in UAE | 4,000 AED | DHA Licensed Molecular Diagnostics Exe...

AAAS Full Gene Sequence Analysis (Allogrove Syndrome) Test

AAAS Full Gene Sequence Analysis (Allogrove Syndrome) in UAE | 4000 AED Executive Summary & Core Metrics...

DPYD Genotyping for 5-Fluorouracil (5-FU) Toxicity & Chemotherapeutic Response Test

DPYD Genotyping for 5-Fluorouracil (5-FU) Toxicity & Chemotherapeutic Response in UAE | 700 AED Executive Summar...

1p & 19q Test

1p & 19q Test in UAE | 1,600 AED | DHA Licensed Executive Summary & Core Metrics โœ… Diagnos...

RHBDF2 Gene Tylosis with Esophageal Cancer Genetic Test

RHBDF2 Gene Tylosis with Esophageal Cancer Genetic Test in UAE | 2,800 AED Executive Summary & Core Metrics...

Cyclin-D1 Immunohistochemistry Test

Cyclin-D1 Immunohistochemistry Test in UAE | 550 AED | DHA-Approved Executive Summary & Core Metrics The Cyc...

BAP1 Tumor Predisposition Syndrome Genetic Test

DHA-Aligned ยท Trusted Genetic Diagnostics BAP1 Tumor Predisposition Syndrome Genetic Test in UAE | 2800 AED | Trust...

VHL Gene (von Hippel-Lindau Syndrome) Genetic Test

VHL Gene (von Hippel-Lindau Syndrome) Genetic Test in UAE | 2,800 AED | DHA Licensed Executive Summary & Core Metri...

Immunohistochemistry Cytomegalovirus (CMV) Test

Immunohistochemistry Cytomegalovirus (CMV) Test in UAE | 550 AED | DHA Licensed | DNA Labs UAE Executive Summary...

ARL11 Gene Tumor Predisposition Syndrome Test

ARL11 Gene Tumor Predisposition Syndrome โ€“ Genetic Test in UAE Executive Summary & Core Metrics Precision ge...

SRGAP1 Gene Mutation Analysis for Hereditary Nonmedullary Thyroid Cancer (Type 2) Test

SRGAP1 Gene Mutation Analysis for Hereditary Nonmedullary Thyroid Cancer (Type 2) in UAE | 2,800 AED Executive Sum...

Myogenin Immunohistochemistry (IHC) Test

Myogenin Immunohistochemistry (IHC) Test in UAE โ€“ Definitive Rhabdomyosarcoma Subtyping Executive Summary & Core Me...